Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vagitocin for vaginal atrophy
NCT02497547Phase 2Completed
- Sponsor
- Peptonic Medical
- Start
- Oct 2014
- Primary completion
- Jul 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin in vaginal atrophy, sponsored by Peptonic Medical. Started Oct 2014; status: completed.
02
Drugs
oxytocin
03
Conditions
vaginal atrophy
Beyond the preview
Go deeper on NCT02497547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02497547.